Susanne Posel ,Chief Editor Occupy Corporatism | The US Independent
May 1, 2014
Researchers at the West China Hospital Department of Radiology at Sichuan University claim that by using functional magnetic resonance imaging (rfMRI) they can accurately decipher an early warning diagnosis for attention deficit hyperactivity disorder (ADHD).
Using the rfMRI, the scientists state that while they can find the “specific brain physiology” that is emphatically known as where ADHD resides, they have been able to locate “widespread brain anomalies” that were previously unknown.
The researchers wrote : “Compared with the fMRI technique, in which the patient has to perform certain tasks relevant to the brain functions to be examined, the rfMRI has no such requirement, and patients just lying in the scanner bed doing nothing, similar to conventional brain scan. It is relatively easy to be implemented in a clinical setting and more comfortably accepted by patients.”
According to the findings, boys that participated in the study were shown to have “altered structure and function . . . in the orbitofrontal cortex” which oversees strategic planning; as well as the globus pallidus which enables “executive inhibitory control” or “the ability to control inappropriate behaviors and responses.”
Other “abnormalities” discovered by the team includes connections “resting-state brain networks linked to executive dysfunction – abnormalities that cause cognitive, emotional and behavioral difficulties.”
Qiyong Gong, lead author of the study stated: “[The] rfMRI may be a useful tool to further investigate the link between brain activity and executive function, which may lead to better characterization of ADHD patients and better understanding of underlying mechanisms of the condition.”
Gong also said: “Our results suggest the potential clinical utility of the rfMRI changes as a useful marker, which may help in diagnosis and in monitoring disease progression and, consequently, may inform timely clinical intervention in the future.”
In 2013, the Food and Drug Administration (FDA) approved a new testing system called Neuropsychiatric EEG-Based Assessment Aid (NEBA) System that measures electrical impulses that neurons give off within the brain to look for evidence of ADHD within a patient’s neural-net.
Christy Foreman, director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health, commented : “Diagnosing ADHD is a multistep process based on a complete medical and psychiatric exam. The NEBA System along with other clinical information may help health care providers more accurately determine if ADHD is the cause of a behavioral problem.”
According to the FDA: “The theta/beta ratio has been shown to be higher in children and adolescents with ADHD than in children without it.”
Earlier this year, Richard Saul, behavioral neurologist at Castle and Connolly Best Doctor in Chicago, explained how ADHD does not exist.
Saul explains: “I have found more than 20 conditions that can lead to symptoms of ADHD, each of which requires its own approach to treatment. Raising a generation of children—and now adults—who can’t live without stimulants is no solution.”
Saul asserts that ADHD has become “an easy catchall phrase that saves time for doctors.”
In this world “as a population, [we] are more distracted today than ever before” and Saul is concerned that the label ADHD is being tossed around for the profit of the drug companies.
Saul said: “Today, the fifth edition of the DSM only requires one to exhibit five of 18 possible symptoms to qualify for an ADHD diagnosis. If you haven’t seen the list, look it up. It will probably bother you. How many of us can claim that we have difficulty with organization or a tendency to lose things; that we are frequently forgetful or distracted or fail to pay close attention to details? Under these subjective criteria, the entire U.S. population could potentially qualify. We’ve all had these moments, and in moderate amounts they’re a normal part of the human condition.”
One good reason to keep people on stimulants under the guise of disease is because stimulants are highly addictive. Saul explains: “The body stops producing the appropriate levels of neurotransmitters that ADHD meds replace — a trademark of addictive substances. I worry that a generation of Americans won’t be able to concentrate without this medication; Big Pharma is understandably not as concerned.”
When a patient is taking stimulants for ADHD, the effects can range from:
• Increased anxiety
• Depressive moods
• Weight loss due to appetite suppression
• Erectile dysfunction
Saul warns that stimulants are a “short-term” answer which is meant to “serve as Band-Aids at best, masking and sometimes exacerbating the source of the problem.”
To break down the misconception, Saul explains that people diagnosed with ADHD are either 1) of a normal level of distraction considering our modern environment, 2) have more acute difficulties are require “individual treatment”.
Saul recommends to his patients diagnosed with ADHD:
• Healthy diet
• Increased exercise
• At least 8 hours of quality sleep
• Minimize caffeine intake
• Monitor cell-phone use
• Find something to be passionate about
Source Article from http://www.occupycorporatism.com/home/incredible-search-adhd-psychotropic-drugs-next-generation/